Skip to main content
. Author manuscript; available in PMC: 2013 Aug 15.
Published in final edited form as: J Psychosom Res. 2011 Jul 18;71(3):117–123. doi: 10.1016/j.jpsychores.2011.04.007

Table 2.

Number (%) of participants who reported having been given a medical diagnosis and who were currently limited by a medical condition along with their mean (SD) PROMIS Fatigue scores.

Medical Condition Number (%)
who have been
given this
diagnosis
Mean (SD)
PROMIS
fatigue Score
of those who
have been
given this
diagnosis
Number (%)
currently
limited by
Mean (SD)
PROMIS
fatigue
Score of
those
currently
limited by
Hypertension 230 (34.5%) 2.1 (0.9) 24 (3.6%) 2.9 (1.1)
Angina 44 (6.6%) 2.5 (1.0) 13 (2.0%) 2.9 (1.0)
Coronary Artery Disease 30 (4.5% 2.2 (1.0) 8 (1.2%) 2.2 (0.8)
Congestive Heart Failure 20 (3.0%) 2.7 (1.1) 13 (2.0%) 2.8 (1.2)
Myocardial Infarction 31 (4.7%) 2.5 (1.1) 6 (0.9%) 2.8 (1.4)
Stroke or Transient Ischemic Attack 25 (3.8%) 2.9 (0.8) 6 (0.9%) 3.3 (0.7)
Liver problem 19 (2.9%) 2.5 (1.0) 4 (0.6%) 3.8 (0.6)
Kidney 17 (2.6%) 2.6 (0.9) 3 (0.5%) 3.3 (0.4)
Arthritis or rheumatism 149 (22.4%) 2.4 (0.9) 77 (11.6%) 2.7 (0.9)
Osteoarthritis or degenerative arthritis 90 (13.5%) 2.4 (0.9) 0 (0.0%)
Migraines or severe headache 94 (14.1%) 2.4 (0.9) 31 (4.7%) 2.6 (0.9)
Asthma 95 (14.3%) 2.3 (0.9) 29 (4.4%) 2.6 (1.0)
Chronic obstructive pulmonary disease, bronchitis, emphysema 31 (4.7%) 2.4 (0.9) 19 (2.9%) 2.8 (0.9)
Diabetes 74 (11.1%) 2.4 (0.9) 16 (2.4%) 3.4 (0.5)
Cancer 41 (6.2%) 2.0 (0.9) 5 (0.8%) 2.4 (0.5)
Depression 136 (20.4%) 2.7 (0.9) 38 (5.7%) 3.4 (0.7)
Anxiety 105 (15.8%) 2.7 (0.9) 33 (5.0%) 3.3 (0.8)
Drug or alcohol (substance) 20 (3.0%) 2.7 (0.9) 1 (0.2%) 4.5
Sleep disorder 71 (10.7%) 2.7 (1.0) 22 (3.3%) 3.2 (0.8)
HIV or AIDS 4 (0.6%) 2.1 (0.6) 0 (0.0%)
Spinal Cord Injury 17 (2.5%) 2.6 (0.6) 11 (1.7%) 2.7 (0.5)
Multiple Sclerosis 5 (0.8%) 3.4 (1.0) 0 (0.0%)
Parkinson’s disease 1 (0.2%) 2.9 0 (0.0%)
Epilepsy 7 (1.1%) 2.6 (1.2) 1 (0.2%) 4.1
Amyotrophic lateral sclerosis 0 (0.0%) 0 (0.0%)

Note: Medical conditions endorsed and current limitations are not mutually exclusive.